Detalhe da pesquisa
1.
Increasing and More Commonly Refractory Mycobacterium avium Pulmonary Disease, Toronto, Ontario, Canada.
Emerg Infect Dis
; 28(8): 1589-1596, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876492
2.
Clinical efficacy and safety of fluoroquinolone containing regimens in patients with Mycobacterium avium complex pulmonary disease.
Eur Respir J
; 55(4)2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980493
3.
Time to Positive Culture Detection Predicts Mycobacterium avium Pulmonary Disease Severity and Treatment Initiation.
Ann Am Thorac Soc
; 19(6): 925-932, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34851813
4.
Aspergillus isolation in nontuberculous mycobacterial pulmonary disease: Associated with antimycobacterial treatment initiation but not response.
Respir Med
; 179: 106338, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33611086
5.
Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada.
BMC Pharmacol Toxicol
; 20(1): 37, 2019 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31159865
6.
Adjuvant lung resection in the management of nontuberculous mycobacterial lung infection: A retrospective matched cohort study.
Respir Med
; 142: 1-6, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30170795